Trial · NCT03990363
Adverse events1,008
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
41 to 60 of 1,008
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Allopurinol | 5 | 171 | 6 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo | 11 | 173 | 11 |
| serious | Bradycardia | Cardiac disorders | High Dose | 0 | 172 | 0 |
| serious | Bradycardia | Cardiac disorders | Intermediate Dose | 0 | 172 | 0 |
| serious | Bradycardia | Cardiac disorders | Low Dose | 1 | 172 | 1 |
| serious | Bradycardia | Cardiac disorders | Switch Dose | 0 | 37 | 0 |
| serious | Bradycardia | Cardiac disorders | Allopurinol | 1 | 171 | 1 |
| serious | Bradycardia | Cardiac disorders | Placebo | 0 | 173 | 0 |
| serious | Tendonitis | Musculoskeletal and connective tissue disorders | High Dose | 0 | 172 | 0 |
| serious | Tendonitis | Musculoskeletal and connective tissue disorders | Intermediate Dose | 0 | 172 | 0 |
| serious | Tendonitis | Musculoskeletal and connective tissue disorders | Low Dose | 0 | 172 | 0 |
| serious | Tendonitis | Musculoskeletal and connective tissue disorders | Switch Dose | 0 | 37 | 0 |
| serious | Tendonitis | Musculoskeletal and connective tissue disorders | Allopurinol | 0 | 171 | 0 |
| serious | Tendonitis | Musculoskeletal and connective tissue disorders | Placebo | 1 | 173 | 1 |
| serious | Adenocarcinoma of colon | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | High Dose | 1 | 172 | 1 |
| serious | Adenocarcinoma of colon | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Intermediate Dose | 0 | 172 | 0 |
| serious | Adenocarcinoma of colon | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Low Dose | 0 | 172 | 0 |
| serious | Adenocarcinoma of colon | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Switch Dose | 0 | 37 | 0 |
| serious | Adenocarcinoma of colon | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Allopurinol | 0 | 171 | 0 |
| serious | Adenocarcinoma of colon | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo | 0 | 173 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03990363/events?page=3